Association between serum ferritin and circulating oxidized low-density lipoprotein levels in patients with type 2 diabetes

Endocrine Journal

Volumn 53, Issue 5, 2006, Pages 665-670

  Ikeda, Yukio ^a   Suehiro, Tadashi ^a   Yamanaka, Shigeo ^a   Kumon, Yoshitaka ^a   Takata, Hiroshi ^a   Inada, Shojiro ^a   Ogami, Naoko ^a   Osaki, Fumiaki ^a   Inoue, Mari ^a   Arii, Kaoru ^a   Hashimoto, Kozo ^a  

^a KOCHI UNIVERSITY   (Japan)

Author keywords

Ferritin; Iron; Oxidized LDL; Type 2 diabetes

Indexed keywords

FERRITIN; IRON; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IRON BLOOD LEVEL; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; FEMALE; FERRITINS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEX CHARACTERISTICS;

EID: 33750606877     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K06-010     Document Type: Article

References (23)

1. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA, Fogelman AM (1996) The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol 16: 831-842.
2. Witztum JL (1994) The oxidation hypothesis of atherosclerosis. Lancet 344: 793-795.
3. Berliner JA, Heinecke JW (1996) The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med 20: 707-727.
4. Steinberg D (1997) Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 272: 20963-20966.
5. Holvoet P, Vanhaecke J, Janssens S, Van de Werf F, Collen D (1998) Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 98: 1487-1494.
6. Holvoet P, Mertens A, Verhamme P, Bogaerts K, Beyens G, Verhaeghe R, Collen D, Muls E, Van de Werf F (2001) Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21: 844-848.
7. Halliwell B (1993) The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 23 (suppl 1): 118-126.
8. Smith C, Mitchinson MJ, Aruoma OI, Halliwell B (1992) Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions. Biochem J 286: 901-905.
9. Thong PS, Selley M, Watt F (1996) Elemental changes in atherosclerotic lesions using nuclear microscopy. Cell Mol Biol 42: 103-110.
10. Abdalla DS, Campa A, Monteiro HP (1992) Low density lipoprotein oxidation by stimulated neutrophils and ferritin. Atherosclerosis 97: 149-159.
11. Juckett MB, Balla J, Balla G, Jessurun J, Jacob HS, Vercellotti GM (1995) Ferritin protects endothelial cells from oxidized low density lipoprotein in vitro. Am J Pathol 147: 782-789.
12. Wolff SP, Jiang ZY, Hunt JV (1991) Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med 10: 339-352.
13. Nourooz-Zadeh J, Tajaddini-Sarmadi J, McCarthy S, Betteridge DJ, Wolff SP (1995) Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 44: 1054-1058.
14. Mowri HO, Frei B, Keaney JF Jr (2000) Glucose enhancement of LDL oxidation is strictly metal ion dependent. Free Radic Biol Med 29: 814-824.
15. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, Edwards PA, Watson AD, Lusis AJ (1995) Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation 91: 2488-2496.
16. Bowie A, Owens D, Collins P, Johnson A, Tomkin GH (1993) Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis 102: 63-67.
17. Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R (1992) High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86: 803-811.
18. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F (1997) Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96: 3300-3307.
19. Danesh J, Appleby P (1999) Coronary heart disease and iron status: meta-analyses of prospective studies. Circulation 99: 852-854.
20. Iribarren C, Sempos CT, Eckfeldt JH, Folsom AR (1998) Lack of association between ferritin level and measures of LDL oxidation: the ARIC study. Atherosclerosis Risk in Communities. Atherosclerosis 139: 189-195.
21. Brouwers A, Langlois M, Delanghe J, Billiet J, De Buyzere M, Vercaemst R, Rietzschel E, Bernard D, Blaton V (2004) Oxidized low-density lipoprotein, iron stores, and haptoglobin polymorphism. Atherosclerosis 176: 189-195.
22. Fernandez-Real JM, Lopez-Bermejo A, Ricart W (2002) Cross-talk between iron metabolism and diabetes. Diabetes 51: 2348-2354.
23. Wilson JG, Lindquist JH, Grambow SC, Crook ED, Maher JF (2003) Potential role of increased iron stores in diabetes. Am J Med Sci 325: 332-339.